Central Venous Catheter Market Report: Trends, Forecast and Competitive Analysis to 2030

Central Venous Catheter Trends and Forecast

The future of the global central venous catheter market looks promising with opportunities in the hospital and cancer treatment center markets. The global central venous catheter market is expected to reach an estimated $4.4 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are increasing prevalence of kidney diseases, growing number of dialysis patients, and expanding demand for antimicrobial catheters.

• Lucintel forecasts that non-tunneled catheter segment will remain larger segment over the forecast period.

• Within this market, hospital will remain larger segment over the forecast period.

• North America will remain the largest region over the forecast period. A more than 150-page report is developed to help in your business decisions.

Emerging Trends in the Central Venous Catheter Market

The central venous catheter market has been undergoing several transformations caused by new developments in materials, configuration, and safety features. These trends are transforming the market and unlocking new avenues for growth.

• Application of Antimicrobial Coating: Embedding antimicrobial coatings on CVCs has become common to minimize the risk of infections. This trend reduces the incidence of catheter-related bloodstream infections (CRBSIs), which pose a significant risk to patients.

• Ultrasound-Guided Insertion: This increase is due to the introduction of the ultrasound-guided approach in CVC insertion, which enhances precise placement and decreases complications. This trend improves the safety of patients as well as their clinical outcomes.

• Catheters with Biofilm-Resistant Materials: Catheters made with biofilm-resistant materials and antibacterial coatings are being developed to prevent fluids from getting stuck within the catheters. This innovation assists in the prevention of infections and extends the life of the catheters.

• Minimally Invasive Designs: There is a growing inclination towards less traumatic CVCs when inserting and removing, which are classified as minimally invasive. This is particularly helpful in the case of children and elderly patients where long-term care is needed.

• Single Lumen Catheters for Targeted Applications: With advancements in medical practice, single-lumen catheters are being strategically designed for specific medical applications such as cancer therapies and kidney dialysis. This trend accommodates the increased need for long-term vascular access for targeted therapy. Those changes—the use of antimicrobial coatings, ultrasound for insertion facilitation, materials resistant to biofilms, minimally invasive designs, and single-lumen catheters—will change the CVC market trend by maximizing safety and care efficiency.

Recent Developments in the Central Venous Catheter Market

The recent developments in the central venous catheter market are focused on both the risks that patients are exposed to and the infection rates associated with the catheter, while also making the catheters more functional. These innovations reflect the rising demand for vascular access that is innovative for long-term use.

• Antimicrobial-Coated Catheters: There has been a new development of CVCs in the form of antimicrobial-coated CVCs, which help to prevent infection. Moreover, this coating is very effective in preventing CRBSIs, thereby minimizing the complication risk related to long-term catheter usage.

• Advanced Catheter Stabilization Devices: Catheter stabilization devices that limit the movement of the catheter and prevent its dislodgment have been widely embraced. These reductions in catheter-related complications are expected to result in a positive impact on patients.

• Biofilm-Resistant Catheters: Another major advancement meant to prevent bacterial infiltration and infection in CVCs is the inclusion of biofilm-resistant materials in the devices. These materials enable longer catheter durations, thereby reducing the frequency of catheter changes.

• Ultrasound-Guided Catheters: The wider usage of ultrasound-guided catheters decreases the rates of placement errors and related complications. Such advancements are especially advantageous for patients with difficult-to-find veins.

• Miniaturized Catheters for Pediatrics: The new miniaturized CVCs used for pediatric care focus on reducing the size of the catheter, allowing for longer use in children with better biocompatibility. These new approaches antimicrobial surface coatings, stabilization devices, biofilm-resistant materials, ultrasound-assisted catheterization, and innovations targeted at pediatric patients are increasing overall safety, decreasing complications, and improving the efficiency of central venous access and catheter use.

Strategic Growth Opportunities for Central Venous Catheter Market

There is an increase in the demand for various innovations in the central venous catheter market, making it a growing field with many strategic opportunities across different healthcare applications. These innovations are lacking in the current market, and if pursued, they will significantly improve access to the target market and enhance patient morbidity and mortality.

• Oncology Treatment: There is an increasing demand for CVCs in oncology due to the rising number of patients requiring CVCs for long-term chemotherapy. This segment of the industry presents a strategic growth opportunity with CVCs engineered for frequent drug supply and blood sampling.

• Dialysis Applications: Chronic kidney disease is on the rise due to diabetes and hypertension, increasing the use of CVCs in dialysis therapy. This presents an important growth opportunity for industry leaders manufacturing catheters suitable for high-flow dialysis processes.

• Pediatric Care: The future growth for specialized and miniaturized CVCs is promising, hence the focus on this area. These types of catheters address the challenge of providing vascular access in children through less invasive procedures over a long term, thus expanding the pediatric vascular access market.

• Intensive Care Units (ICUs): The role of CVCs in ICUs for critical care management is increasing. There is potential for market growth in catheters that offer long-term venous access while reducing the risk of infection.

• Home Healthcare Solutions: There has been a shift in emphasis from institution-based healthcare services to home-based healthcare services. As such, CVCs designed for home use, particularly for managing chronic diseases and long-term treatments, provide a market opportunity for manufacturers. Core expansion opportunities in oncology, dialysis, pediatrics, critical care units (ICUs), and home healthcare are expanding the CVC market as innovation continues to focus on specific patient situations and prolonged care.

Central Venous Catheter Market Driver and Challenges

The central venous catheter market is influenced by bundled technological, economic, and regulatory factors. At the same time, the industry faces several primary challenges that must be addressed to ensure ongoing growth and innovation. The factors driving the central venous catheter market include:

• Rising Demand for Long-Term Care: There has been a growing trend towards chronic conditions that require dedicated care for patients, which has pushed the CVC market. These catheters are important vascular access devices for prolonged therapies.

• Technological Advancements: Market expansion has been significantly driven by product development, aided by innovations such as antimicrobial coatings and biofilm-inhibiting materials.

• Growing Prevalence of Chronic Diseases: The increasing number of chronic conditions, including cancer and kidney disease, boosts the market for CVCs, which are primary means of drug delivery and dialysis.

• Increased Focus on Infection Prevention: Advancements in catheter technology that reduce catheter-related complications and ensure better insertion techniques are encouraging healthcare professionals to adopt more advanced CVCs with various safety designs.

• Growth of Home Healthcare: The increase in the use of home-based healthcare services, especially for chronic diseases, is driving the demand for CVCs that can be used safely in unsupervised environments. Challenges in the central venous catheter market are:

• High Risk of Infection: Nonetheless, CVCs that have been in use for prolonged periods are still associated with high morbidity rates due to complications related to infection. Infection prevention remains a significant obstacle for all manufacturers.

• Cost of Advanced Technologies: The acceptance and application of CVCs with advanced features, such as built-in antimicrobial properties, are cost-restrictive, particularly in developing countries.

• Regulatory Hurdles: Different countries have varying regulatory guidelines, some of which may be challenging for manufacturers, especially for medical device companies. Medical device regulations are evolving, requiring manufacturers to frequently update their approvals and certifications. Expansion of major factors like rising demand for long-term care and the growth of home healthcare is driving CVC market growth. Nevertheless, these markets have challenges to be addressed to enable better control over infection risks, costs, regulations, and market competition.

List of Central Venous Catheter Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies central venous catheter companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the central venous catheter companies profiled in this report include-

• Rex Medical

• B. Braun

• Teleflex

• AngioDynamics

• ICU Medical

• Vygon

• Medtronic

• Merit Medical Systems

• Asahi Kasei

• Becton, Dickinson and Company

Central Venous Catheter by Segment

The study includes a forecast for the global central venous catheter by product type, property, design, end use, and region.

Central Venous Catheter Market by Product Type [Analysis by Value from 2018 to 2030]:

• Tunneled Catheters

• Non-Tunneled Catheters

Central Venous Catheter Market by Property [Analysis by Value from 2018 to 2030]:

• Antimicrobial Catheters

• Non-Antimicrobial Catheters

Central Venous Catheter Market by Design [Analysis by Value from 2018 to 2030]:

• Single Lumen

• Double Lumen

• Multiple Lumen

Central Venous Catheter Market by End Use [Analysis by Value from 2018 to 2030]:

• Hospital

• Cancer Treatment Centers

• Others

Central Venous Catheter Market by Region [Analysis by Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Central Venous Catheter Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The image below highlights recent developments by major central venous catheter manufacturers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., the use of antimicrobial-coated CVCs is gaining popularity due to the decreasing trend of catheter-related infections. Recent innovations include improved approaches to catheter insertion and the development of ultrasound-guided catheters for better patient care.

• China: The demand for advanced healthcare infrastructure in China is fueling the growth of the Chinese CVC market. Recent developments include the incorporation of antibacterial elements into CVCs to prevent infections and the creation of low-cost but high-quality catheter options.

• Germany: The German market for central venous catheters focuses on modern technologies that can prevent infections. Examples include the integration of biofilm-preventing materials and optimization of catheter securement methods to decrease risks associated with prolonged catheterization.

• India: The increasing prevalence of long-term care needs among the population in Intensive Care Units and oncology departments in India has led to a rise in the usage of central venous catheters. Recent developments have focused on low-cost solutions that improve safety for patients, particularly those requiring long-term catheterization.

• Japan: In addition to the principles mentioned above, Japan is pursuing the miniaturization of CVCs and developing more innovative biocompatible options. The nation is also integrating minimally invasive methods and advanced technologies that enhance the accuracy and safety of catheter devices, particularly for younger and older individuals.

Features of the Global Central Venous Catheter Market

Market Size Estimates: Central venous catheter market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Central venous catheter market size by various segments, such as by product type, property, design, end use, and region in terms of value ($B). Regional Analysis: Central venous catheter market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different product types, properties, designs, end uses, and regions for the central venous catheter market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the central venous catheter market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the central venous catheter market size? Answer: The global central venous catheter market is expected to reach an estimated $4.4 billion by 2030. Q2. What is the growth forecast for central venous catheter market? Answer: The global central venous catheter market is expected to grow with a CAGR of 6.5% from 2024 to 2030. Q3. What are the major drivers influencing the growth of the central venous catheter market? Answer: The major drivers for this market are increasing prevalence of kidney diseases, growing number of dialysis patients, and expanding demand for antimicrobial catheters. Q4. What are the major segments for central venous catheter market? Answer: The future of the central venous catheter market looks promising with opportunities in the hospital and cancer treatment center markets. Q5. Who are the key central venous catheter market companies? Answer: Some of the key central venous catheter companies are as follows:

• Rex Medical

• B. Braun

• Teleflex

• AngioDynamics

• ICU Medical

• Vygon

• Medtronic

• Merit Medical Systems

• Asahi Kasei

• Becton, Dickinson and Company Q6. Which central venous catheter market segment will be the largest in future? Answer: Lucintel forecasts that non-tunneled catheter segment will remain larger segment over the forecast period. Q7. In central venous catheter market, which region is expected to be the largest in next 5 years? Answer: North America will remain the largest region over the forecast period. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.